China Lysosomal Storage Disorder Drugs Market to 2032
Overview
The China Lysosomal Storage Disorder Drugs Market is expected to reach a 1,040.79 USD Million by 2032 and is projected to grow at a CAGR of 15.53% from 2025 to 2032.
Revenue, 2024 (USD Million)
378.99
Forecast, 2032 (USD Million)
1,040.79
CAGR, 2024 - 2032
15.53%
Report Coverage
China
China Lysosomal Storage Disorder Drugs Market 2018-2032 USD Million
China Lysosomal Storage Disorder Drugs Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 378.99 USD Million
- Projected Market Size (2032): 1,040.79 USD Million
- CAGR (2025-2032): 15.53%
Key Findings of China Lysosomal Storage Disorder Drugs Market
- The China Lysosomal Storage Disorder Drugs Market was valued at 378.99 USD Million in 2024.
- The China Lysosomal Storage Disorder Drugs Market is likely to grow at a CAGR of 15.53% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Hospital Pharmacies in Distribution Channel Segment accounted for the largest share of the market with a revenue of 263.35 USD Million
- The fastest growing segment Imiglucerase in Drugs Segment grew Fastest with a CAGR of 18.05% during the forecast period from 2024 to 2032.
China Lysosomal Storage Disorder Drugs Market Scope
China Lysosomal Storage Disorder Drugs Market Segmentation & Scope
Type
- Others
- Chaperone Therapy
- Substrate Reduction Therapy (SRT)
- Enzyme Replacement Therapy (ERT)
Drugs
- Others
- Avalglucosidase Alfa
- Galsulfase
- Agalsidase Alpha
- Laronidase
- Taliglucerase Alfa
- Velaglucerase
- Alglucosidase Alpha
- Idursulfase
- Agalsidase Beta
- Imiglucerase
Route of Administration
- Others
- Oral
- Subcutaneous (SC)
- Intravenous (IV)
Age Group
- Geriatric
- Adults
- Pediatric
Distribution Channel
- Online Pharmacies
- Drugs Stores and Retail Pharmacies
- Hospital Pharmacies
Type of Disorder
- Others
- Krabbe Disease
- Niemann-Pick Disease
- Mucopolysaccharidosis (MPS)
- Pompe Disease
- Fabry Disease
- Gaucher Disease
Gender
- Female
- Male
China Lysosomal Storage Disorder Drugs Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2023 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 378.99 USD Million |
| Market Value in 2032 | 1,040.79 USD Million |
| CAGR (2025-2032) | 15.53% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Type,Drugs,Route of Administration,Age Group,Distribution Channel,Type of Disorder,Gender |
Regional Insights:
-
Leading Market (2024-2032): China, leading in terms of revenue 378.99 USD Million in 2024
- Key Country: China, leading in terms of revenue with value of 378.99 USD Million in 2024.
Segments and Scope
-
China Lysosomal Storage Disorder Drugs Market to 2032, By Type
- Enzyme Replacement Therapy (ERT) is the largest segment in China Lysosomal Storage Disorder Drugs Market to 2032 with a revenue of 250.13 USD Million in the year 2024.
- Substrate Reduction Therapy (SRT) is the Fastest growing segment in China Lysosomal Storage Disorder Drugs Market to 2032 with a Growth rate of 15.37 % in forecast period 2025-2032.
-
China Lysosomal Storage Disorder Drugs Market to 2032, By Drugs
- Imiglucerase is the largest segment in China Lysosomal Storage Disorder Drugs Market to 2032 with a revenue of 92.27 USD Million in the year 2024.
- Imiglucerase is the Fastest growing segment in China Lysosomal Storage Disorder Drugs Market to 2032 with a Growth rate of 18.05 % in forecast period 2025-2032.
-
China Lysosomal Storage Disorder Drugs Market to 2032, By Route of Administration
- Intravenous (IV) is the largest segment in China Lysosomal Storage Disorder Drugs Market to 2032 with a revenue of 223.46 USD Million in the year 2024.
- Subcutaneous (SC) is the Fastest growing segment in China Lysosomal Storage Disorder Drugs Market to 2032 with a Growth rate of 14.90 % in forecast period 2025-2032.
-
China Lysosomal Storage Disorder Drugs Market to 2032, By Age Group
- Pediatric is the largest segment in China Lysosomal Storage Disorder Drugs Market to 2032 with a revenue of 165.18 USD Million in the year 2024.
- Pediatric is the Fastest growing segment in China Lysosomal Storage Disorder Drugs Market to 2032 with a Growth rate of 16.59 % in forecast period 2025-2032.
-
China Lysosomal Storage Disorder Drugs Market to 2032, By Distribution Channel
- Hospital Pharmacies is the largest segment in China Lysosomal Storage Disorder Drugs Market to 2032 with a revenue of 263.35 USD Million in the year 2024.
- Online Pharmacies is the Fastest growing segment in China Lysosomal Storage Disorder Drugs Market to 2032 with a Growth rate of 15.67 % in forecast period 2025-2032.
-
China Lysosomal Storage Disorder Drugs Market to 2032, By Type of Disorder
- Gaucher Disease is the largest segment in China Lysosomal Storage Disorder Drugs Market to 2032 with a revenue of 138.37 USD Million in the year 2024.
- Gaucher Disease is the Fastest growing segment in China Lysosomal Storage Disorder Drugs Market to 2032 with a Growth rate of 16.50 % in forecast period 2025-2032.
-
China Lysosomal Storage Disorder Drugs Market to 2032, By Gender
- Male is the largest segment in China Lysosomal Storage Disorder Drugs Market to 2032 with a revenue of 215.45 USD Million in the year 2024.
- Male is the Fastest growing segment in China Lysosomal Storage Disorder Drugs Market to 2032 with a Growth rate of 16.35 % in forecast period 2025-2032.
China Lysosomal Storage Disorder Drugs Market Company Share Analysis
| Company Name |
|
||
| Takeda Pharmaceutical Company Limited | |||
| Pfizer Inc. | |||
| Sanofi | |||
| BioMarin | |||
| Amicus Therapeutics, Inc. | |||
China Lysosomal Storage Disorder Drugs Market Geographical Sales Distribution, 2018-2032 USD Million
China Lysosomal Storage Disorder Drugs Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The China Lysosomal Storage Disorder Drugs Market is segmented based on Segmentation Type,Drugs,Route of Administration,Age Group,Distribution Channel,Type of Disorder,Gender.
China Lysosomal Storage Disorder Drugs Market was valued at USD 378.99(Revenue in USD Million) in 2023.
China Lysosomal Storage Disorder Drugs Market is projected to grow at a CAGR of 15.53% during the forecast period of 2024 to 2032.
The Hospital Pharmacies segment is expected to dominate the China Lysosomal Storage Disorder Drugs Market, holding a largest market share of 263.35 USD Million in 2024
China Lysosomal Storage Disorder Drugs Market Scope
China Lysosomal Storage Disorder Drugs Market Segmentation & Scope
Type
- Others
- Chaperone Therapy
- Substrate Reduction Therapy (SRT)
- Enzyme Replacement Therapy (ERT)
Drugs
- Others
- Avalglucosidase Alfa
- Galsulfase
- Agalsidase Alpha
- Laronidase
- Taliglucerase Alfa
- Velaglucerase
- Alglucosidase Alpha
- Idursulfase
- Agalsidase Beta
- Imiglucerase
Route of Administration
- Others
- Oral
- Subcutaneous (SC)
- Intravenous (IV)
Age Group
- Geriatric
- Adults
- Pediatric
Distribution Channel
- Online Pharmacies
- Drugs Stores and Retail Pharmacies
- Hospital Pharmacies
Type of Disorder
- Others
- Krabbe Disease
- Niemann-Pick Disease
- Mucopolysaccharidosis (MPS)
- Pompe Disease
- Fabry Disease
- Gaucher Disease
Gender
- Female
- Male
Frequently Asked Questions
The China Lysosomal Storage Disorder Drugs Market is segmented based on Segmentation Type,Drugs,Route of Administration,Age Group,Distribution Channel,Type of Disorder,Gender.
China Lysosomal Storage Disorder Drugs Market was valued at USD 378.99(Revenue in USD Million) in 2023.
China Lysosomal Storage Disorder Drugs Market is projected to grow at a CAGR of 15.53% during the forecast period of 2024 to 2032.
The estimated market value of the China Lysosomal Storage Disorder Drugs Market for final year is USD 1,040.79 (USD Million).
China Lysosomal Storage Disorder Drugs Market Company Profiling
Frequently Asked Questions
The China Lysosomal Storage Disorder Drugs Market is segmented based on Segmentation Type,Drugs,Route of Administration,Age Group,Distribution Channel,Type of Disorder,Gender.
China Lysosomal Storage Disorder Drugs Market was valued at USD 378.99(Revenue in USD Million) in 2023.
China Lysosomal Storage Disorder Drugs Market is projected to grow at a CAGR of 15.53% during the forecast period of 2024 to 2032.
The estimated market value of the China Lysosomal Storage Disorder Drugs Market for final year is USD 1,040.79 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.